Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Announces Third Quarter 2017 Financial Results And Provides Company Update
Atossa Genetics Applauds Newly-Introduced Federal Legislation Requiring That Breast Density Be Reported To Physicians and Patients
Atossa Genetics Announces Closing of $5.5 Million Common Stock Public Offering and Over-allotment Option
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!